The deal involves Eli Lilly, which makes Zepbound and Mounjaro, and Novo Nordisk, the maker of Ozempic and Wegovy. The drugs, known as GLP-1 medications, now cost as much as $1,350 a month. Under the ...
Kansas turned in a 60-page application last week in hopes of receiving a share of $50 billion in federal money designed to ...
North Carolina already reduced Medicaid reimbursement rates. Now hard-hit rural hospitals are now bracing for federal cuts.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback